(Q41552354)

3 October 2017

Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody (English)

1 reference

3 October 2017

0 references

Y Dohi

1

1 reference

3 October 2017

S Sunada

2

1 reference

3 October 2017

M Aoki

3

1 reference

3 October 2017

A Moriguchi

4

1 reference

3 October 2017

M Okabayashi

5

1 reference

3 October 2017

M Miyata

6

1 reference

3 October 2017

H Matsuda

7

1 reference

3 October 2017

1 June 1993

1 reference

Cancer Immunology, Immunotherapy

3 October 2017

1 reference

3 October 2017

36

1 reference

3 October 2017

357-363

1 reference

3 October 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01742251

3 October 2017

0 references

cites work

Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells

1 reference

12 December 2020

In vivo administration of anti-CD3 prevents malignant progressor tumor growth

1 reference

12 December 2020

Tumor necrosis factor: receptors on hematopoietic cells

1 reference

12 December 2020

Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones

1 reference

12 December 2020

Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro

1 reference

12 December 2020

Augmentation of antileukemia lytic activity by OKT3 monoclonal antibody: synergism of OKT3 and interleukin-2.

1 reference

12 December 2020

Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.

1 reference

12 December 2020

Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells

1 reference

12 December 2020

Identification of a monoclonal antibody specific for a murine T3 polypeptide

1 reference

12 December 2020

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

12 December 2020

Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism

1 reference

12 December 2020

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

1 reference

12 December 2020

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

12 December 2020

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta

1 reference

12 December 2020

1 reference

12 December 2020

High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors

1 reference

12 December 2020

Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.

1 reference

12 December 2020

Analysis of TNF alpha-induced DNA strand breaks at the single cell level

1 reference

12 December 2020

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

1 reference

12 December 2020

CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC

1 reference

12 December 2020

Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing

1 reference

12 December 2020

Homology of perforin to the ninth component of complement (C9).

1 reference

12 December 2020

Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01742251

1 reference

Dimensions Publication ID

3 October 2017

0 references

1 reference